IPT Quality Innovation Prevention And Productivity (QIPP)

Quality, Innovation, Prevention and Productivity (QIPP)

QIPP stands for Quality, Innovation, Productivity and Prevention and has been designed to complement not supplement policies such as World Class Commissioning, the nNational Service Frameworks, the National Institute for Clinical Excellence on CSII and The NHS Next Stage Review: High Quality Care for All Report. QIPP focuses on the NHS working in different ways to ensure that the highest quality care is delivered. It encourages efficiency and focuses on a 'joined up' approach to delivering healthcare.

Click Here for an image that highlights how the different components of QIPP intertwine together (source: NHS Institute for Innovation and Improvement).

QIPP Explained

See below for a full explanation of how implementation of the technology meets its overarching principles.

Quality

Implementation of the technology meets the 'Quality' aspect of QIPP as there will be possible reductions in hospital admissions, it facilitates reduced severe hypoglycaemia, it can delay the onset and slow the progression of various long-term complications - which can have a positive impact on diabetes services across the NHS and patients produce higher coping abilities and thus lower anxiety and depression scores.

The NHS Next Stage Review: High Quality Care for All document describes quality as needing to be consistently safe, clinically effective and personal. This can be categorised into three elements:

  1. Experience - Providing patients and carers with the best possible experience through their pathway. Patients should have access to services that are personalised and should feel that the staff who provide services care about what happens to them. Providing a quality service must induce a high degree of personalisation, compassion, dignity and respect.
  2. Safety - Getting the basics right, first time, every time and making sure that people are not harmed as a result of what is being delivered, is an essential component to delivering high quality healthcare. This relates primarily to patients but does also apply to the staff who are delivering the care and the environment in which it is being delivered.
  3. Effectiveness - Providing the best treatment available, ensuring that all our providers adopt NICE guidance appropriate to their services and we can see that they are providing clinically effective services because they demonstrate it through clinical audit and better outcomes.

Innovation

Implementation of the technology meets the 'Innovation' aspect of QIPP as Trusts become referring centres whereby patients can receive insulin pump therapy as routine clinical care (with patent choice at the forefront of the services delivered), type 1 patients with effective diabetes control can delay the onset and slow the progression of various long-term complications and insulin pump therapy introduces a high degree of service improvement as efficiency places itself high on the agenda.

Ensuring that the technology becomes embedded into the service requires the need to demonstrate the beneficial effect its implementation will have. Innovation is used in a variety of contexts in the NHS, but the focus here must remain on the delivery on a strong service improvement model, which is facilitated by the introduction of this technology and thus a revised model of care for diabetes patients.

Implementation may mean different things to different NHS organisations. It may be that implementation of the technology is taken forward by a local Diabetes Network across more than one hospital in a given area. A PCT may decide to take a regional approach to adoption. Innovation is this context is important - who is going to be the champion for change?

Prevention

This is a key part of the QIPP programme which recognises that if we prevent people becoming ill or getting sicker we will save lives, improve quality of life, add years to people's lives and prevent dependency on health services in the long term. Implementation of the technology not only lowers HbA1c for patients (thus improving quality of life for all), but it also has the potential to provide patients with higher coping abilities and thus lower anxiety and depression scores within a short space of time and associated morbidity.

There is also a case that The NHS Next Stage Review: High Quality Care for All document and nNational Service Frameworks (NSFs) and National Institute for Clinical Excellence (NICE) guidance. In practice this means that commissioned services must reflect the ever-growing expectations of the services being delivered from patients and their carers. Systematically involving patients will help to shape the delivery of the diabetes service and ensure that the is fully embraced. Communicating the benefits of the technology (e.g. introducing better general health for diabetes patients) to all stakeholders will be an important part in realising the benefits of implementation.

Productivity

Productivity is a measure of the output or outcome compared to the input. Quality and productivity are not mutually exclusive and through quality improvement programmes productivity usually gains. Productivity is, to some degree, the spine behind the QIPP agenda and is the strand that will highlight to Trusts if the implementation of the technology has achieved the anticipated benefits.

Essentially, the productivity strand of QIPP will mean that there will be possible reductions in hospital admissions (and therefore resource on local health economies), Trusts become referring centres whereby patients can receive insulin pump therapy as routine clinical care (with patent choice at the forefront of the services delivered) and it provides greater family cohesion and higher treatment satisfaction. There is also the potential to reduce follow-up appointments after a given point in time. Measuring the impact of the productivity strand will be an essential aspect of the implementation of this technology, and building it into the Trusts regular performance reviews will ensure that the process is governed appropriately.

Click Here to download a Service Requirement Document which highlights the de and re-commissioning processes that, if put in place, will be key indicators behind measuring productivity changes as a result of implementation of the technology.

Downloadable Resources

Follow Us

For the latest news on our activities follow us on Twitter and Linked-In

twitter
linkedin
rss

Join The Discussion

Welcome to the How To Why To Guide

The NHS Technology Adoption Centre How To Why To Guides. They are designed to provide you with information about innovative medical technologies, the benefits and barriers to adoption along with practical implementation tools for your organisation.

Please agree to the terms and conditions below before entering the site.

1. Agreement

1.1 This freely accessible version of the How To Why To Guide is a generalised assessment version of a select number of Technology Implementation Projects undertaken by the NHS Technology Adoption Centre ("NTAC) that has been provided to allow you to see how adoption processes operates (the ´Guides´). The Guides are produced and made available by The NHS Technology Adoption Centre. By accessing the Guides you ("you") agree to these Terms.

1.2 These Terms form the agreement between you and us. If you do not agree to be legally bound by these Terms please leave this section of the website immediately. Your continued access and use of the website and/or the How To Why To Guide will amount to acceptance.

1.3 You are hereby granted a non-transferable, non-exclusive licence to view the Guides for your personal assessment and non-commercial purposes until your access is terminated by us.

2. Disclaimer

2.1 Liability

2.1.1 Neither NTAC, nor its contributors shall be held liable for any improper or incorrect use of the information described and/or contained on this site and NTAC assumes no responsibility for anyone´s use of the information.

2.1.2 In no event shall NTAC, or contributors be liable for any direct, indirect, incidental, special, exemplary, or consequential damages (including, but not limited to, procurement or substitute goods or services; loss of use, data, or profits; or business interruption) however caused and on any theory of liability, whether in contract, strict liability, or tort (including negligence or otherwise) arising in any way out of the use of this site or system.

2.1.3 This disclaimer of liability applies to any damages or injury, including but not limited to those caused by any failure of performance, error, omission, interruption, deletion, defect, delay in operation or transmission, computer virus, communication line failure, theft or destruction or unauthorized access to, alteration of, or use of record, whether for breach of contract, tortuous behaviour, negligence or under any other cause of action.

2.2 Warranties/Accuracy of Information

2.2.1 Although the data found using the NTAC site has been produced and processed from sources believed to be reliable, no warranty expressed or implied is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information.

2.2.2 This disclaimer applies to both isolated and aggregate uses of the information. NTAC provides this information on an "as is" basis. All warranties of any kind express or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses and non-infringement of proprietary rights ARE DISCLAIMED.

2.2.3 Changes may be periodically added to the information contained in our "How to why to guides "; these changes may or may not be incorporated in any new version of the guide. If you have obtained information on the NTAC site from a source other than NTAC, please be aware that electronic data can be altered subsequent to original distribution. Data can also quickly become out-of-date.

2.3 Endorsement

2.3.1 NTAC is a distributor of content sometimes supplied by third parties and users. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by third parties, including information providers, users, or others, are those of the respective author(s) or distributor(s) and do not necessarily state or reflect those of NTAC and shall not be used for advertising or product endorsement purposes.

2.3.2 Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not constitute or imply its endorsement, recommendation, or favouring by NTAC.

2.4 Duty to Continue Provision of "How to why to Guides"

2.4.1 Due to the dynamic nature of the Internet, resources that are publicly available one day may require restriction of access the next, and the location of items may change as menus, homepages, and files are reorganised.

2.4.2 User expressly agrees that use of NTAC site is at the user's sole risk. Neither NTAC, any entity jointly created by them, each of their affiliates nor any of their respective employees, agency, third party content providers or licenser warrant that the service will be uninterrupted or error free.

2.5 Conflicts of Interest

2.5.1 Neither NTAC, nor its contributors, have received any corporate sponsorship nor hold any financial interest in the companies manufacturing technologies described in our How to why to Guides.

3. Restrictions and intellectual property rights

3.1 The How To Why To Guide contains copyright material, trade names and marks and other proprietary information, including, but not limited to, text, software, photos and graphics ("Content"). The Content is protected by copyright law, database rights and other intellectual property rights.

3.2 The information contained here may not be converted into any other format, or transmitted in any other way, without the consent of the authors. While we encourage hyper-links to be made to this site from other parts of the Web, the pages cannot be copied and saved onto other Web servers in order to be transmitted from those servers, without permission from NTAC. This prohibition applies to those who intend to make copies of this information to retransmit as part of other Web sites; it does not apply to other Web servers which store pages for routine caching purposes.

3.3 In the event of any authorised copying, redistribution or publication of copyright material, no changes in or deletion of author attribution, trademark legend or copyright notice shall be made. You acknowledge that you do not acquire any ownership rights by downloading copyright material.

4. Limitation of liability / indemnity

You agree to defend, indemnify, and hold harmless, NTAC, its contributors, any entity jointly created by them, their respective affiliates and their respective directors, officers, employees, and agents from and against all claims and expenses, including legal fees, arising out of the use of this site or service by user or user's account.

5. External links

5.1 Every effort is made to ensure that access to the How To Why To Guide is uninterrupted and that transmissions will be error-free. However, we cannot, due to the nature of the internet, guarantee that your access will not be suspended from time to time including to allow for repairs, maintenance or the introduction of new content or facilities.

5.2 NTAC, nor its contributors are responsible for the contents of any off-site pages referenced. The user specifically acknowledges that neither NTAC or its contributors is liable for the defamatory, offensive, or illegal conduct of other users, links, or third parties and that the risk of injury from the foregoing rests entirely with the user.

5.3 The How To Why To Guide contains links including hyperlinks which may take you outside of http://www.technologyadoptioncentre.nhs.uk/how-to-why-to-guides.html. Links are provided for your convenience, and an inclusion of any link does not imply endorsement or approval by us of the linked website, its operator or content. These links are provided as an information service only. It is the responsibility to the web surfer to evaluate the content and usefulness of information obtained from other sites.

6. Governing law

6.1 These Terms are governed by English law notwithstanding the jurisdiction where you are based. You irrevocably agree that the courts of England shall have exclusive jurisdiction to settle any dispute which may arise out of, under, or in connection with these Terms and for those purposes irrevocably submit all disputes to the jurisdiction of the English courts. The place of performance shall be England.

6.2 We provide no warranty or guarantee that the Website or information available on it complies with laws other than those of England.

6.3 If any provision (or part) of this agreement is found by any court of competent jurisdiction or administrative body to be invalid, unenforceable or illegal, the other provisions shall remain in force.

7. Further information

7.1 Further information or any queries on them can be obtained from NHS Technology Adoption Centre


I agree to the terms & conditions